Inactive Instrument

Calendar Zynex Inc. Other OTC

Equities

US98986M1036

Chart calendar Zynex Inc.

4884741accc5e71550c43944394c1.vFtctat7jQGWHeACj9Sltxrw0mzlEVvfASRgutxLWbk.zyo-_uAJ4U3UdtM63q319U-yjSSzXhSnS0oJ_b4MBsrpMgPy_zfOdMJYtQ~879e3b3598a442e28b5664020bbbcecc

Upcoming events on Zynex Inc.

25/07/2024 Q2 2024 Earnings Release (Projected)
29/10/2024 Q3 2024 Earnings Release (Projected)
27/02/2025 Q4 2024 Earnings Release (Projected)
06/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Zynex Inc.

13/06/2024 08:30 pm RBC Capital Markets Medical Device Strategy & Innovation Conference
16/05/2024 08:30 pm Annual General Meeting
16/05/2024 12:35 am RBC Capital Markets Global Healthcare Conference
01/05/2024 01:45 am Q1 2024 Earnings Call
01/05/2024 01:31 am Q1 2024 Earnings Release
01/03/2024 02:45 am Q4 2023 Earnings Call
01/03/2024 02:31 am Q4 2023 Earnings Release
16/01/2024 Needham Growth Conference
27/10/2023 01:45 am Q3 2023 Earnings Call
27/10/2023 01:31 am Q3 2023 Earnings Release
26/09/2023 11:05 pm Cantor Global Healthcare Conference
13/09/2023 12:30 am H.C. Wainwright Global Investment Conference
28/07/2023 01:45 am Q2 2023 Earnings Call
28/07/2023 01:31 am Q2 2023 Earnings Release
17/05/2023 Annual General Meeting
28/04/2023 01:45 am Q1 2023 Earnings Call
28/04/2023 01:31 am Q1 2023 Earnings Release
13/03/2023 06:00 pm Q4 2022 Earnings Call
13/03/2023 05:30 pm Q4 2022 Earnings Release
01/12/2022 03:00 am Piper Sandler Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
45,5
45,1
0.86%
80,1
80,3
-0.24%
130
131
-0.73%
158
159
-0.57%
184
192
-3.82%

227

EBITDA
Million USD
Released
Forecast
Spread
12,1
12,0
1.34%
13,7
13,5
0.99%
26,7
26,3
1.33%
28,1
27,9
0.68%
22,3
22,8
-2.35%

30,5

EBIT
Million USD
Released
Forecast
Spread
11,1
10,7
3.52%
10,2
10,6
-3.19%
22,4
20,6
8.38%
22,9
22,9
0.1%
10,8
17,9
-39.93%

23,8

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
11,9
11,6
3.2%
10,2
10,9
-6.63%
22,3
20,5
8.5%
22,2
22,5
-1.31%
12,6
18,4
-31.52%

21,7

Net income
Million USD
Released
Forecast
Spread
9,49
9,06
4.77%
9,07
9,54
-4.89%
17,1
15,7
8.81%
17,0
16,9
1.03%
9,73
14,4
-32.26%

16,3

EPS
USD
Released
Forecast
Spread
0,25
0,24
5%
0,24
0,25
-3.7%
0,44
0,40
9.4%
0,44
0,43
3.12%
0,27
0,41
-33.5%

0,49

Announcement Date27/02/2025/02/2124/02/2213/03/2329/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
31,1
31,0
0.21%
36,8
36,3
1.27%
41,5
41,4
0.22%
48,8
49,7
-1.83%
42,2
39,6
6.45%
45,0
44,7
0.67%
49,9
49,9
0.08%
47,3
55,6
-14.99%
46,5
47,7
-2.44%

52,1


60,2


68,1


57,9


65,9

EBITDA
Million USD
Released
Forecast
Spread
3,07
3,40
-9.69%
5,54
4,85
14.19%
8,13
7,67
6%
11,4
11,2
1.68%
1,01
2,20
-53.92%
4,01
5,22
-23.14%
7,29
5,90
23.68%
9,94
9,79
1.55%
1,69
3,14
-46.34%

5,36


9,15


14,4


5,49


10,3

EBIT
Million USD
Released
Forecast
Spread
1,91
2,40
-20.49%
4,36
3,93
10.93%
6,56
6,56
-0.05%
10,1
10,1
0.2%
0,28
0,79
-63.96%
2,71
2,31
17.7%
5,49
4,78
14.72%
2,30
8,43
-72.73%
0,53
1,84
-71.52%

3,83


7,39


12,1


3,19


7,78

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
1,98
2,34
-15.14%
4,15
3,86
7.51%
6,35
6,51
-2.48%
9,72
10,0
-2.96%
1,60
0,76
110.42%
4,10
2,27
80.84%
4,95
4,38
12.99%
1,93
7,83
-75.34%
0,01
1,42
-99.09%

3,32


6,85


11,5


2,74


7,33

Net income
Million USD
Released
Forecast
Spread
1,38
1,81
-23.82%
3,35
2,81
19.17%
4,87
4,69
3.8%
7,45
7,28
2.41%
1,57
0,58
168.97%
3,35
1,75
91.38%
3,59
3,42
5.16%
1,22
5,95
-79.56%
0,01
1,09
-99.08%

2,50


5,17


8,68


2,03


5,50

EPS
USD
Released
Forecast
Spread
0,03
0,05
-36.84%
0,08
0,07
10.34%
0,13
0,12
8.33%
0,20
0,19
5.26%
0,04
0,01
200.08%
0,09
0,05
100%
0,10
0,09
7.15%
0,04
0,17
-76.47%
0,00
0,03
-

0,08


0,15


0,26


0,08


0,17

Announcement Date28/04/2228/07/2227/10/2213/03/2327/04/2327/07/2326/10/2329/02/2430/04/24-----